FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE
FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE · ONE OF JUST 8 NATIONWIDE
Medically reviewed by Uri Gedalia, MD, FACS
Chief Medical Officer, TrufaMED Urgent Care & Concierge Medicine
Board-Certified, General Surgery
Last reviewed: June 2026
NAD+ IV therapy has gone from biohacker fringe to mainstream wellness in the last five years. Bryan Johnson uses it, Joe Rogan uses it, and a meaningful subset of Miami's longevity-curious patients now ask about it by name. The question we get most often: is it actually worth $1,000?
This post is a candid clinical walkthrough — what NAD+ is, what the research does and does not support, what the actual protocol looks like at our Surfside clinic, who we recommend it for, and who should probably skip it.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme that every mitochondrion in your body uses to convert food into ATP — the energy currency of cellular metabolism. NAD+ levels decline with age, and the decline correlates with reduced mitochondrial function, slower DNA repair, and various age-associated metabolic patterns.
The intuition behind NAD+ supplementation: restore the substrate and you restore the downstream machinery. The reality is more nuanced. NAD+ supports many enzymes (sirtuins, PARPs, CD38) and the effect of restoring extracellular levels via IV is not the same as restoring intracellular levels in every tissue.
Where the evidence is reasonable:
Where the evidence is preliminary:
Where the evidence does not support claims:
Our standard NAD+ protocol delivers 500 mg of NAD+ in a 500 ml saline base. The drip rate is slow — this is critical for tolerability.
We do not run NAD+ at a single fixed flat rate. Patients new to NAD+ start at a slower drip rate and titrate up as tolerated. The slow drip is what differentiates a comfortable infusion from a nauseating one. We have heard from patients who experienced rapid NAD+ infusions elsewhere as ‘the worst hour of my life’; we run slower deliberately.
Most patients tolerate NAD+ infusions well when run slowly. Some sensations are common and benign:
If any sensation becomes uncomfortable the RN slows the rate. Adjustments are routine, not failures.
There is no universal protocol. Common patterns at our clinic:
Most patients notice effects after the first or second session, with cumulative effects after the loading phase. Some patients notice nothing meaningful, which is also a legitimate finding.
NAD+ is not FDA-approved for any specific clinical indication; use is off-label and considered investigational for most applications. Quality of the NAD+ supplied by your provider matters; we source from a US-licensed compounding pharmacy.
We do offer NAD+ as mobile IV in select cases, though most patients prefer in-clinic for the 3-4 hour duration and access to physician oversight. Discuss with the booking team.
Oral NMN and NR can raise NAD+ levels with daily use, but bioavailability is lower than IV. IV produces a high transient peak; oral produces a steadier rise. They are not mutually exclusive; some patients do both.
Yes. NAD+ IV therapy in Miami is generally priced $750 to $1,500 per session depending on the dose and provider. Our $1,000 single price covers 500 mg in a slow 3-4 hour infusion with physician oversight.
Book urgent care, IV therapy, HBOT and telehealth, track your wellness, and reach your care team, all from the app.